Santa Cruz Biotechnology delivers a wide array of ZNF452 monoclonal antibodies for research focused on understanding ZNF452 protein function. ZNF452 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ZNF452, a member of the zinc finger protein family, plays essential roles in transcriptional regulation and DNA binding. ZNF452 maintains genomic stability and regulates gene expression, making it a key focus in cellular differentiation and development research. Research has shown that ZNF452 activity influences various cellular pathways and processes. Understanding ZNF452 function can reveal important insights into disease mechanisms, particularly in cancer where transcription factor regulation is frequently altered. Investigating ZNF452 expression patterns helps illuminate its role in normal development and disease progression. Current research continues to uncover new functions and interactions of ZNF452 in cellular processes. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of ZNF452's role in health and disease.